Merck shares went south today on news that a study published in 2000 in The New England Journal of Medicine excluded data that might have linked the drug to an increase in heart attacks.
As first reported on Forbes.com, editors at the world's top medical journal found by examining a computer diskette that relevant data about Vioxx's risk to the heart compared with an older pain drug, naproxen, were deleted two days before the paper was initially submitted.
Insiders view: Hmm! That's the trouble with technology sometimes. It can leave ghosts in the machine!
Here's the NEJM piece:
NEJM
Here is the NJ Star Ledgers take:
Star Ledger
No comments:
Post a Comment